Boulding Mark Elliott sold PTCT
February 18, 2026 · Form 4 insider transaction
Boulding Mark Elliott sold 3,081 shares of PTC Therapeutics, Inc. at $69.36 per share, a transaction worth $213.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,081
Price
$69.36
Total value
$213.7K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 18, 2026
Filing dateFebruary 19, 2026
Shares owned after108,231
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,500 RSUs from a February 15, 2024 grant of 18,000 RSUs and the vesting of 1,600 RSUs from a February 15, 2024 grant of 3,200 RSUs.